Drug Penetration Enhancers - A Practical Guide for Formulators
Posted: Mon Mar 09, 2026 12:51 am
What Are Penetration Enhancers?
"Penetration enhancers" (also called permeation or absorption enhancers) are formulation ingredients or strategies that temporarily increase the rate and/or extent a drug crosses a biological barrier — most commonly the stratum corneum (skin) or intestinal/mucosal epithelium — without permanently damaging tissue. They are widely used to expand the range of molecules that can be delivered non-invasively (e.g., small lipophilic drugs by transdermal patch, peptides by oral or buccal routes) and to improve onset, bioavailability, or local bioactivity.
Transdermal Penetration Enhancers
The skin's outermost layer, the stratum corneum, is a highly ordered "brick-and-mortar" barrier of corneocytes embedded in lipid bilayers. Effective transdermal enhancers transiently change either the lipid domain, the protein domain, or the partitioning/solubility of the drug so more of it crosses into viable epidermis and dermis.
Practical formulation notes
Use the lowest effective concentration to minimize irritation.
Combination strategies often work best (e.g., ethanol + terpene + humectant) because they target complementary barriers.
Monitor skin irritation (in vitro / ex vivo skin and in vivo patch tests) during development; some powerful enhancers (DMSO, strong surfactants) have limited regulatory acceptability.
Oral Penetration Enhancers (Intestinal / Mucosal)
Why Oral Enhancers Matter?
Oral delivery of biologics (peptides/proteins) and other macromolecules is a major unmet need. Chemical permeation enhancers (PEs) are a core enabling technology for oral peptide products that rely on transiently increasing epithelial uptake and/or protecting molecules from luminal degradation.
Major Classes & Mechanisms
Medium-chain fatty acids / salts (e.g., sodium caprate, "C10")
Mechanism: Increase paracellular permeability by transiently opening tight junctions and perturbing membrane lipids; evidence supports both paracellular and transcellular contributions depending on context and concentration. Sodium caprate is one of the best-studied clinical-stage enhancers for oral peptide delivery. It was used across multiple investigational oral peptide projects. Developers optimize concentration, buffer conditions, and dosage form to achieve absorption while limiting mucosal irritation.
Salts like SNAC (salcaprozate sodium)
Mechanism: For semaglutide, SNAC appears to act in the stomach in a local manner to (a) promote transcellular absorption by modifying the local microenvironment (making it more lipophilic and protecting peptide from acid/proteolysis) and (b) enhance membrane uptake without opening tight junctions. This route enabled the first marketed oral peptide of its class. Regulatory filings and reviews explain SNAC's specific role in semaglutide development.
Enzyme inhibitors & protease inhibitors
Mechanism: Reduce luminal or brush-border degradation of peptide drugs, used together with permeation enhancers.
Mucoadhesive & polymeric systems (e.g., chitosan and derivatives)
Mechanism: Prolong residence time at absorption site and can modulate tight junctions (reversible opening), improving uptake. Chitosan is a widely studied mucoadhesive enhancer for nasal, buccal and intestinal delivery.
Lipid-based colloidal systems / nanoparticles
Mechanism: Formulation vehicles (liposomes, solid lipid nanoparticles, self-emulsifying drug delivery systems) that promote transcellular uptake or protect cargo until uptake occurs.
Mechanistic Nuance — SNAC vs. C10
Recent comparative studies show distinct modes of action: sodium caprate (C10) tends to favor paracellular mechanisms (tight junction modulation) and concentration-dependent membrane effects, while SNAC's dominant effect in clinically successful oral semaglutide formulations is local solubilization/protection and facilitation of transcellular uptake in the stomach. Understanding the mechanism is essential because safety and site of action depend on it.
"Penetration enhancers" (also called permeation or absorption enhancers) are formulation ingredients or strategies that temporarily increase the rate and/or extent a drug crosses a biological barrier — most commonly the stratum corneum (skin) or intestinal/mucosal epithelium — without permanently damaging tissue. They are widely used to expand the range of molecules that can be delivered non-invasively (e.g., small lipophilic drugs by transdermal patch, peptides by oral or buccal routes) and to improve onset, bioavailability, or local bioactivity.
Transdermal Penetration Enhancers
The skin's outermost layer, the stratum corneum, is a highly ordered "brick-and-mortar" barrier of corneocytes embedded in lipid bilayers. Effective transdermal enhancers transiently change either the lipid domain, the protein domain, or the partitioning/solubility of the drug so more of it crosses into viable epidermis and dermis.
Practical formulation notes
Use the lowest effective concentration to minimize irritation.
Combination strategies often work best (e.g., ethanol + terpene + humectant) because they target complementary barriers.
Monitor skin irritation (in vitro / ex vivo skin and in vivo patch tests) during development; some powerful enhancers (DMSO, strong surfactants) have limited regulatory acceptability.
Oral Penetration Enhancers (Intestinal / Mucosal)
Why Oral Enhancers Matter?
Oral delivery of biologics (peptides/proteins) and other macromolecules is a major unmet need. Chemical permeation enhancers (PEs) are a core enabling technology for oral peptide products that rely on transiently increasing epithelial uptake and/or protecting molecules from luminal degradation.
Major Classes & Mechanisms
Medium-chain fatty acids / salts (e.g., sodium caprate, "C10")
Mechanism: Increase paracellular permeability by transiently opening tight junctions and perturbing membrane lipids; evidence supports both paracellular and transcellular contributions depending on context and concentration. Sodium caprate is one of the best-studied clinical-stage enhancers for oral peptide delivery. It was used across multiple investigational oral peptide projects. Developers optimize concentration, buffer conditions, and dosage form to achieve absorption while limiting mucosal irritation.
Salts like SNAC (salcaprozate sodium)
Mechanism: For semaglutide, SNAC appears to act in the stomach in a local manner to (a) promote transcellular absorption by modifying the local microenvironment (making it more lipophilic and protecting peptide from acid/proteolysis) and (b) enhance membrane uptake without opening tight junctions. This route enabled the first marketed oral peptide of its class. Regulatory filings and reviews explain SNAC's specific role in semaglutide development.
Enzyme inhibitors & protease inhibitors
Mechanism: Reduce luminal or brush-border degradation of peptide drugs, used together with permeation enhancers.
Mucoadhesive & polymeric systems (e.g., chitosan and derivatives)
Mechanism: Prolong residence time at absorption site and can modulate tight junctions (reversible opening), improving uptake. Chitosan is a widely studied mucoadhesive enhancer for nasal, buccal and intestinal delivery.
Lipid-based colloidal systems / nanoparticles
Mechanism: Formulation vehicles (liposomes, solid lipid nanoparticles, self-emulsifying drug delivery systems) that promote transcellular uptake or protect cargo until uptake occurs.
Mechanistic Nuance — SNAC vs. C10
Recent comparative studies show distinct modes of action: sodium caprate (C10) tends to favor paracellular mechanisms (tight junction modulation) and concentration-dependent membrane effects, while SNAC's dominant effect in clinically successful oral semaglutide formulations is local solubilization/protection and facilitation of transcellular uptake in the stomach. Understanding the mechanism is essential because safety and site of action depend on it.